Page 85 - Latest Updates on Q4 Results

Icra Q4 net profit up 14.5% YoY to Rs 38.6 cr; revenue rises 16.4%

Consolidated revenue from operations increased by 17.6 per cent YoY to Rs 403.2 crore in FY23

APM Terminals Pipavav Q4 profit rises 31%, Ebitda stands at Rs 129.94 cr

APM Terminals Pipavav (Gujarat Pipavav Port Ltd) on Wednesday reported a 31 per cent rise in consolidated net profit at Rs 98.13 crore for the fourth quarter of the year ended March 2023. The company had reported a profit of Rs 75.09 crore in the corresponding period a year ago. According to a company statement, revenue from operations for the fourth quarter under consideration stood at Rs 234.73 crore as against Rs 219.67 crore in the year-ago period. EBITDA for the quarter was Rs 129.94 crore from Rs 127.98 crore in Q4FY22. For the financial year ended March 31, 2023, the company reported a net profit of Rs 313.81 crore, growth of 59 per cent as compared with Rs 197.68 crore in FY22. Revenue for the fiscal year stood at Rs 916.95 crore as against Rs 741.36 crore a year ago. The container cargo business for the quarter stood at 1,99,000 TEUs, showing a robust growth of 22 per cent. APM Terminals Pipavav is one of India's leading gateway ports for containers, dry bulk cargoes, l

JB Pharma Q4 PAT rises 3.5% to Rs 88 cr, revenue stands at Rs 762 cr

JB Pharma on Wednesday said its profit after tax rose by 3.5 per cent to Rs 88 crore for the fourth quarter ended March 31, 2023. The company had reported a profit after tax (PAT) at Rs 85 crore in the January-March quarter of 2021-22 fiscal. Revenue of the company stood at Rs 762 crore in the fourth quarter of FY23 as against Rs 625 crore in the same period of FY22, JB Pharma said in a statement. For the last fiscal, the company reported revenue of Rs 3,149 crore as compared with Rs 2,424 crore in FY22. During the same period, PAT stood at Rs 410 crore as against Rs 386 crore, recording a growth of 6 per cent, JB Pharma said. The drug maker continued its growth journey in the fourth quarter, thereby ending FY23 with a strong performance across business segments, JB Pharma CEO Nikhil Chopra said. "While we are cautious of the inflationary environment our efforts are aimed at executing well, with productivity and cost optimisation as drivers, in order to deliver improved operating

Brigade Enterprises Q4 profit at Rs 63 cr, FY23 profit stands at 222 cr

Realty firm Brigade Enterprises Ltd on Wednesday reported a consolidated net profit of Rs 63 crore for the quarter ended March 2023. The company posted a net loss of Rs 11.63 crore in the year-ago period. Total income fell to Rs 872.11 crore in the fourth quarter of the last fiscal from Rs 964.72 crore in the corresponding period of the previous year, according to a regulatory filing. Net profit stood at Rs 222.17 crore in the last fiscal as against a net loss of Rs 64.76 crore in the 2021-22 financial year. Total income rose to Rs 3,563.21 crore in the 2022-23 fiscal from Rs 3,065.51 crore in the previous year. Commenting on the results, Pavitra Shankar, Managing Director, Brigade Enterprises Ltd said, "...our real estate business outperformed during the fourth quarter, enabling us to end the year with highest ever sales. Leasing and hospitality also contributed significantly to the overall growth of the company in 2022-23." The company has a strong pipeline of ongoing projects

Hitachi Energy net profit dips 1.68% to Rs 51 cr in March quarter

Hitachi Energy on Wednesday said its net profit dipped 1.68 per cent to Rs 50.81 crore in March quarter 2022-23. The company reported a net profit of Rs 51.68 crore for the year-ago period, according to a BSE filing. Total income rose to Rs 1,336.30 crore from Rs 1,142.13 crore in the same period a year ago. The company received an order worth Rs 1,262 crore in the fourth quarter, which was higher than Rs 1,043.6 crore in the year-ago period. As of March 31, 2023, the order backlog stood at Rs 7,071 crore, providing revenue visibility for the coming quarters, it stated. "Our success is a result of our focused strategy, diversified portfolio, and relentless pursuit for improving the bottomline," N Venu, Managing Director and Chief Executive Officer of Hitachi Energy India, said in a statement. He stated that the price of certain commodities specific to this industry remain high and chips & electronics shortage persists. "We have resiliently navigated these challenges and remain .

Nykaa Q4 results: Net profit falls 71%, revenue from operations up 33%

Nykaa's Ebitda rose 84 per cent to Rs 70.6 crore during the quarter

Sensex drops 208 pts, Nifty below 18,300; metal, financial stocks weak

CLOSING BELL: Adani Enterprises fell over 6 per cent, while Adani Ports, Tata Motors, HDFC, HDFC Bank, ICICI Bank, Reliance Industries, HUL, and Asian Paints declined up to 2 per cent

Cummins reports 61% jump in Q4 profit on robust domestic, int'l demand

The company reported consolidated profit after tax at 3.49 billion rupees ($42.7 million) in the three months ended March 31, compared to 2.16 billion rupees a year earlier

Hindalco Q4 results: Profit falls 48% to Rs 832 cr, Rs 3 dividend declared

During the quarter, the company's revenue from operations rose to Rs 19,995 crore from Rs 18,969 crore in Q4FY22

Gains in Delhivery dependent on a sustained improvement in margins

Increasing volumes while cutting costs would be a major challenge

Dreamfolks hits record high; rallies 16% in two days on healthy Q4 results

The stock hit a record high of Rs 592.15 in intra-day today, and was trading 82 per cent higher against its issue price of Rs 326 per share.

Lenovo India logs $1.9 bn in FY23, over 5 mn products being made locally

While Group revenue was impacted due to the softness in the device market, revenue from non-PC businesses reached a fiscal year high of nearly 40%

Ceat hits new summit; zooms over 46% so far this May on strong Q4 results

The management is hopeful that the coming quarters will see further uptick in growth, as commodity prices remain stable, and the global inflation slows down.

Fortis Healthcare net profit rises 59% to Rs 138 cr in March quarter

Fortis Healthcare on Tuesday said its consolidated net profit increased 59 per cent to Rs 138 crore for the March quarter, on the back of strong performance in the hospital business. The healthcare major had reported a net profit of Rs 87 crore in the January-March quarter of 2021-22 fiscal. Total income rose to Rs 1,656 crore in the fourth quarter over Rs 1,384 crore in the fourth quarter of 2021-22 fiscal, Fortis Healthcare said in a statement. For the year ended March 31, 2023, the company's net profit declined to Rs 633 crore as against Rs 790 crore in 2021-22 fiscal. However, adjusted PAT (profit after tax) of the company stood at Rs 559 crore for the last fiscal as compared with Rs 475 crore in FY22, the company added. Fortis Healthcare Chairman Ravi Rajagopal said the hospital business continues to perform well across all financial and operating parameters. "We remain well-positioned for our next phase of growth comprising brownfield bed expansion in order to expand and cr

Dixon Technologies profit climbs 27.7% to Rs 80.62 cr in March quarter

Dixon Technologies (India) Ltd on Tuesday reported a 27.7 per cent rise in consolidated net profit at Rs 80.62 crore for the fourth quarter ended March 31, 2023. The company had posted a net profit of Rs 63.13 crore for the January-March period a year ago, the electronic manufacturing services firm said in a BSE filing. Its revenue from operations increased 3.81 per cent to Rs 3,065.45 crore as against Rs 2,952.75 crore in the year-ago period. Total expenses of Dixon Technologies were Rs 2,956.76 crore, up 3.10 per cent in Q4FY23. Dixon Technologies' total income in the March quarter was at Rs 3,067.27 crore. For the fiscal ended March 2023, Dixon Technologies net profit climbed 34 per cent to Rs 255.08 crore. It reported a net profit of Rs 190.33 crore in FY22. Its consolidated revenue from operations was Rs 12,192.01 crore in FY23, 14 per cent higher than the preceding fiscal. Its board, in a meeting held on Tuesday, recommended a final dividend Rs 3 per equity share of the fa

Biocon Q4 results: Net profit rises 31% to Rs 313 cr, revenue up 57%

For the entire financial year, the company's net profit saw a decline of 29 per cent to Rs 462.7 crore, as compared to Rs 648.4 crore in 2021-22

Strong Q4 performance, robust cash flows and outlook to support BPCL stock

Attractive valuations and robust cash flows are the other positives

Amara Raja Batteries posts 41% rise in Q4 net profit; revenue up 11%

During the period under review, the company's revenue from operations also saw an increase of 11 per cent to Rs 2,429 crore, from Rs 2,181 crore during Q4 FY22

Amara Raja Batteries Q4 results: Consolidated profit rises 41% to Rs 139 cr

The company's consolidated revenue from operation rose by 11.37 per cent to Rs 2,429 crore for the March quarter

NMDC Q4 results: Net profit rises 22% to Rs 2,277 cr, revenue falls 13%

The company's revenue from operation fell by 13.76 per cent to Rs 5,851 crore for the March quarter as compared to Rs 6,785 crore in the year-ago period